Pancreatic cancer (PC) is known to be frequently associated with venous thromboembolism (VTE). Although treatment and prophylaxis strategies for VTE in PC patients were updated recently, these were mainly based on data from Western populations and were not verified in East Asian ethnic populations.We investigated the clinical characteristics of VTE in East Asian PC patients. We reviewed electronic medical records (EMR) of 1334 patients diagnosed with pancreatic adenocarcinoma from 2005 to 2010 at single tertiary hospital in Korea. All the patients with newly diagnosed VTE were classified by anatomical site and manifestation of symptoms. The primary outcomes of interest were 2-year cumulative incidence of VTE events. Cox proportional hazards...
Objective Few data regarding the incidence of cancer-associated thromboembolism (TE) are available f...
The connection between pancreatic cancer and venous thrombosis has been discussed for almost 150 yea...
International audienceExocrine pancreatic ductal adenocarcinoma, simply referred to as pancreatic ca...
BACKGROUND: Pancreatic adenocarcinoma is one of the cancers most frequently associated with venous t...
Objective Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deat...
Introduction: Pancreatic cancer is associated with a high risk of venous thromboembolism (VTE). Howe...
Background: Venous thromboembolism (VTE) is a clinically significant complication that is well docum...
International audienceAmong cancers, pancreatic cancer is known to be associated with a higher incid...
Background: Few studies have explored the association between pancreatic cancer and arterial thrombo...
[[abstract]]Background Unprovoked (idiopathic) venous thromboembolism (VTE) with no obvious antecede...
Objective: The study aimed to identify the risk factors involved in initiating thromboembolism (TE) ...
BACKGROUND: The prognosis of patients with cancer-venous thromboembolism (VTE) is not well known bec...
Pancreatic cancer remains a major clinical challenge. Recent advances in chemotherapeutic and target...
BACKGROUND: Differences in outcome among cancer patients with incidental versus symptomatic venous t...
BACKGROUNDRisk factors for cancer-associated VTE include certain cancer types (e.g. pancreatic adeno...
Objective Few data regarding the incidence of cancer-associated thromboembolism (TE) are available f...
The connection between pancreatic cancer and venous thrombosis has been discussed for almost 150 yea...
International audienceExocrine pancreatic ductal adenocarcinoma, simply referred to as pancreatic ca...
BACKGROUND: Pancreatic adenocarcinoma is one of the cancers most frequently associated with venous t...
Objective Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deat...
Introduction: Pancreatic cancer is associated with a high risk of venous thromboembolism (VTE). Howe...
Background: Venous thromboembolism (VTE) is a clinically significant complication that is well docum...
International audienceAmong cancers, pancreatic cancer is known to be associated with a higher incid...
Background: Few studies have explored the association between pancreatic cancer and arterial thrombo...
[[abstract]]Background Unprovoked (idiopathic) venous thromboembolism (VTE) with no obvious antecede...
Objective: The study aimed to identify the risk factors involved in initiating thromboembolism (TE) ...
BACKGROUND: The prognosis of patients with cancer-venous thromboembolism (VTE) is not well known bec...
Pancreatic cancer remains a major clinical challenge. Recent advances in chemotherapeutic and target...
BACKGROUND: Differences in outcome among cancer patients with incidental versus symptomatic venous t...
BACKGROUNDRisk factors for cancer-associated VTE include certain cancer types (e.g. pancreatic adeno...
Objective Few data regarding the incidence of cancer-associated thromboembolism (TE) are available f...
The connection between pancreatic cancer and venous thrombosis has been discussed for almost 150 yea...
International audienceExocrine pancreatic ductal adenocarcinoma, simply referred to as pancreatic ca...